Cofactor raises $18M in series A

On Sept. 18, precision medicine company Cofactor Genomics Inc. (San Francisco, Calif.) raised $18 million in an oversubscribed series A round led by Menlo Ventures. Data Collective, Ascension Ventures, iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and Stanford also participated.

Cofactor Genomics' CLIA-validated Pinnacle assay measures the expression of nearly 600 RNA biomarkers known to be associated with response to targeted therapeutics. The company's Paragon test is an RNA-based immunophenotyping assay that profiles the cellular components of the tumor microenvironment...